Search Results - "Hayat Caidi"

Refine Results
  1. 1

    HLA alleles associated with COVID-19 susceptibility and severity in different populations: a systematic review by Fakhkhari, Meryem, Caidi, Hayat, Sadki, Khalid

    Published in Egyptian Journal of Medical Human Genetics (01-01-2023)
    “…Background COVID-19 is a respiratory disease caused by a novel coronavirus called as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Detected for…”
    Get full text
    Journal Article
  2. 2

    Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses by Trivedi, Suvang U., Miao, Congrong, Sanchez, Joseph E., Caidi, Hayat, Tamin, Azaibi, Haynes, Lia, Thornburg, Natalie J.

    Published in Scientific reports (04-02-2019)
    “…Known human coronaviruses (hCoV) usually cause mild to moderate upper-respiratory tract illnesses, except SARS-CoV and MERS-CoV, which, in addition to mild…”
    Get full text
    Journal Article
  3. 3

    Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model by Caidi, Hayat, Miao, Congrong, Thornburg, Natalie J., Tripp, Ralph A., Anderson, Larry J., Haynes, Lia M.

    Published in Antiviral research (01-06-2018)
    “…RSV continues to be a high priority for vaccine and antiviral drug development. Unfortunately, no safe and effective RSV vaccine is available and treatment…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    RSV Growth and Quantification by Microtitration and qRT-PCR Assays by Caidi, Hayat, Harcourt, Jennifer L, Haynes, Lia M

    “…Defective interfering viral particles have been reported as important determinants of the course of viral infection, and they can markedly temper the virulence…”
    Get more information
    Journal Article
  8. 8

    Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice by Caidi, Hayat, Harcourt, Jennifer L, Tripp, Ralph A, Anderson, Larry J, Haynes, Lia M

    Published in PloS one (27-12-2012)
    “…Therapeutic options to control respiratory syncytial virus (RSV) are limited, thus development of new therapeutics is high priority. Previous studies with a…”
    Get full text
    Journal Article
  9. 9

    Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice by Radu, Gertrud U, Caidi, Hayat, Miao, Congrong, Tripp, Ralph A, Anderson, Larry J, Haynes, Lia M

    Published in Journal of Virology (01-09-2010)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice by Rey, Gertrud U, Miao, Congrong, Caidi, Hayat, Trivedi, Suvang U, Harcourt, Jennifer L, Tripp, Ralph A, Anderson, Larry J, Haynes, Lia M

    Published in PloS one (23-12-2013)
    “…Respiratory syncytial virus (RSV) is a high priority target for vaccine development. One concern in RSV vaccine development is that a non-live virus vaccine…”
    Get full text
    Journal Article
  12. 12

    Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection by Harcourt, Jennifer L., Caidi, Hayat, Anderson, Larry J., Haynes, Lia M.

    Published in Journal of virological methods (01-06-2011)
    “…Respiratory syncytial virus (RSV) replication is primarily limited to the upper respiratory tract epithelium and primary, differentiated normal human bronchial…”
    Get full text
    Journal Article
  13. 13

    Genotyping Measles Virus by Real-Time Amplification Refractory Mutation System PCR Represents a Rapid Approach for Measles Outbreak Investigations by Waku-Kouomou, Diane, Alla, Amal, Blanquier, Bariza, Jeantet, Damien, Caidi, Hayat, Rguig, Ahmed, Freymuth, François, Wild, Fabian T

    Published in Journal of Clinical Microbiology (01-02-2006)
    “…Real-time PCR has been developed to genotype measles virus (MV) isolates. MV strains circulating in epidemics in Gabon in 1984, Cameroon in 2001, Morocco in…”
    Get full text
    Journal Article
  14. 14

    Vibrio species: development of EUCAST susceptibility testing methods and MIC and zone diameter distributions on which to determine clinical breakpoints by Karatuna, Onur, Matuschek, Erika, Åhman, Jenny, Caidi, Hayat, Kahlmeter, Gunnar

    Published in Journal of antimicrobial chemotherapy (01-02-2024)
    “…Abstract Objectives Most human infections caused by Vibrio spp. do not warrant antimicrobial treatment but in severe cases, targeted antimicrobial treatment…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    165. Emergence of Extensively Drug-Resistant Salmonella enterica Serotype Typhi Infections—United States, 2008–2020 by Medalla, Felicita, Watkins, Louise Francois, Hughes, Michael, Birhane, Meseret, Dorough, Layne, Griffin, Chelsey, Reynolds, Jared, Caidi, Hayat, Webb, Hattie E, Mintz, Eric, Gutelius, Bruce, Langley, Gayle

    Published in Open forum infectious diseases (04-12-2021)
    “…Abstract Background Typhoid fever, caused by Salmonella Typhi, is fatal in 12%–30% of patients not treated with appropriate antibiotics. In 2016, a large…”
    Get full text
    Journal Article